Neurotoxicity
12 drugs4,456 FAERS reportsMedDRA PT
GET
/api/v1/reaction/neurotoxicityReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Neurotoxicity (12)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Axicabtagene Ciloleucel1,36314%
- 2Lisocabtagene Maraleucel10213%
- 3Penpulimab411%
- 4Tisagenlecleucel4189.4%
- 5Obecabtagene Autoleucel26.7%
- 6Idecabtagene Vicleucel756.5%
- 7Nelarabine606.3%
- 8Ciltacabtagene Autoleucel1773.5%
- 9Oxaliplatin1,4562.0%
- 10Teclistamab301.5%
- 11Blinatumomab574—
- 12Brexucabtagene Autoleucel195—
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Immune Effector Cell-associated Neurotoxicity Syndrome9 shared · 0.50
- Hypogammaglobulinaemia4 shared · 0.27
- Cytokine Release Syndrome9 shared · 0.23
- Acute Lymphocytic Leukaemia Recurrent3 shared · 0.21
- Cytopenia4 shared · 0.18
- Aphasia3 shared · 0.16
- Haemophagocytic Lymphohistiocytosis2 shared · 0.14
- Diffuse Large B-cell Lymphoma2 shared · 0.11
- Plasma Cell Myeloma3 shared · 0.09
- Encephalopathy3 shared · 0.09
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.